Skip to main content

DHT.U.TO

Stock
Healthcare
Pharmaceuticals

Performance overview

DHT.U.TO Price
Price Chart

Forward-looking statistics

Beta
0.22
Risk
39.54%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Provides capital to biopharmaceutical innovators through ownership and acquisition of pharmaceutical royalties.

Company info

SectorHealthcare
IndustryPharmaceuticals
Website—
Employees—
Market cap$596.0M

Fundamentals

Enterprise value$894.3M
Revenue$184.9M
Revenue per employee—
Profit margin0.77%
Debt to equity80.55

Security info

ExchangeToronto Stock Exchange
Type of shareCommon Stock
Earnings per share (EPS)$0.03
Dividend per share—
Revenue per share$3.28
Avg trading volume (30 day)$106
Avg trading volume (10 day)$106
Put-call ratio—

Macro factor sensitivity

Growth+0.4
Credit+7.1
Liquidity+3.9
Inflation-5.3
Commodities-1.2
Interest Rates+0.5

Valuation

Dividend yield4.24%
PEG Ratio9.72
Price to sales2.87
P/E Ratio9.72
Enterprise Value to Revenue4.84
Price to book1.02

Upcoming events

Next earnings dayMarch 1, 2023
Next dividend day—
Ex. dividend dayJune 30, 2025

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free